CTS 2024: Faricimab vs aflibercept in the reduction of exudates in Y/R trials
June 10th 2024Jennifer Lim, MD, FARVO, spoke with us about her presentation Faricimab vs aflibercept in the reduction of exudates in Y/R trials" at Clinical Trials at the Summit meeting in Park City, Utah on June 8, 2024.
Read More
Study: Taking electroretinography to the next level with soft multi-electrode system
May 31st 2024According to researchers at Waseda University in Japan, the proposed device can measure electrical potentials from different places in the retina simultaneously, which is useful in diagnosing eye diseases.
Read More
Study: High-frequency electrical ‘noise’ may result in congenital night blindness
May 22nd 2024Researchers note the G90D mutation in rhodopsin is known to produce background electrical noise to desensitize rods, but the nature of the ‘noise’ and its precise molecular source have not been resolved for almost 30 years.
Read More
Prevent Blindness kicks off ‘It Started With an Eye Exam’
May 21st 2024The campaign will encourage, educate and empower the public to include vision and eye health as a part of their healthcare by asking them to share how eye care services and exams improved their vision and their daily lives.
Read More
ARVO 2024: Reduction in hard exudates with faricimab vs aflibercept in patients with DME
May 19th 2024At this year's ARVO meeting, Roger Goldberg, MD, presented a paper on hard exudates and their resolution in patients with diabetic macular edema treated with either faricimab or 2 mg aflibercept.
Read More
ARVO 2024: Exploratory analysis of pivotal phase 3 trials, YOSEMITE and RHINE, for vabysmo in DME
May 18th 2024At this year's ARVO meeting, Daniela Ferrara, MD, PhD, FASRS, presented a paper on predicting functional outcomes for different treatment durations of faricimab in diabetic macular edema.
Read More
ARVO 2024: Feasibility and clinical efficacy of an OCT B-scan of interest tool
May 16th 2024At this year's ARVO meeting in Seattle, Washington, the Eye Care Network spoke with Niranchana Manivannan, PhD. She spoke about the poster presentation, "Feasibility and clinical efficacy of an OCT B-scan of interest tool."
Read More
Study: Virus that causes COVID-19 can penetrate blood-retinal barrier and may damage vision
May 15th 2024Researchers at the University of Missouri School of Medicine have conducted a study in a humanized mouse model to show that infections can occur deep inside the eye by penetrating the blood-retinal barrier.
Read More
ARVO 2024: Predicting 3-year myopia control efficacy from 1-year data
May 13th 2024At this year's ARVO meeting in Seattle, Washington, the Eye Care Network spoke with Noel Brennan, MScOptom, PhD. The clinical research fellow at Johnson and Johnson shared highlights from his presentation on myopia control and predictive modeling.
Read More